Form 4: Progressive Corp Director Philip Bleser Receives Restricted Stock Grant
SEC Form 4 Filing
Director Philip Bleser received a restricted stock grant from Progressive Corp as part of his compensation for the 2025-2026 term.
Summary
- Philip Bleser, a director of Progressive Corp, filed a Form 4 disclosing changes in beneficial ownership.
- The filing reports a restricted stock grant of 739 shares awarded on May 9, 2025, with a value of $0 at the time of the grant.
- These shares are part of Bleser's compensation for the 2025-2026 term under the company's Amended and Restated 2017 Directors Equity Incentive Plan.
- The restricted stock will vest on April 10, 2026.
- Bleser elected to receive 60% of his compensation in restricted stock and 40% in cash.
- The Compensation and Talent Committee approved the restricted stock award and authorized a cash payment for the remaining 40% of his compensation, payable on April 10, 2026.
- Bleser has granted power of attorney to several individuals to handle SEC filings on his behalf.
Sentiment
Score: 7
Explanation: The document reflects a routine director compensation matter, indicating stable corporate governance and alignment of interests. The sentiment is neutral to slightly positive.
Positives
- The restricted stock grant aligns the director's interests with those of the shareholders.
- The compensation structure provides a mix of equity and cash, offering both long-term incentives and immediate value.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting date of the restricted stock and the cash payment date.
Industry Context
Director compensation packages often include a mix of cash and equity to incentivize performance and align interests with shareholders. Restricted stock grants are a common component of these packages.
Comparison to Industry Standards
- Progressive's director compensation structure, including the mix of restricted stock and cash, is consistent with practices at comparable insurance companies such as Allstate, Geico (Berkshire Hathaway), and State Farm.
- These companies also utilize equity-based compensation to align director and shareholder interests.
- The vesting schedule of the restricted stock, approximately one year from the grant date, is a typical timeframe for such awards.
Stakeholder Impact
- Shareholders may view the equity-based compensation as a positive sign, aligning director interests with long-term company performance.
- The compensation structure is unlikely to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| May 8, 2025 | Date of Power of Attorney execution by Philip Bleser. |
| May 9, 2025 | Date of restricted stock grant to Philip Bleser. |
| April 10, 2026 | Vesting date for the restricted stock grant and date of cash payment. |
| October 23, 2026 | Expiration date of Margaret A. Rose's Notary Public commission. |
Keywords
Progressive Corp, Director Compensation, Restricted Stock, Form 4, Beneficial Ownership, Equity Incentive Plan, Power of Attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.